NYSE:JNJ - Johnson & Johnson Stock Price, News & Analysis

$129.67
+0.13 (+0.10 %)
(As of 09/17/2019 04:00 PM ET)
Today's Range
$129.11
Now: $129.67
$130.50
50-Day Range
$127.05
MA: $130.12
$133.79
52-Week Range
$121.00
Now: $129.67
$148.99
Volume5.00 million shs
Average Volume7.07 million shs
Market Capitalization$342.22 billion
P/E Ratio15.85
Dividend Yield2.93%
Beta0.68
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP47816010
Phone732-524-0400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$81.58 billion
Cash Flow$10.8148 per share
Book Value$22.28 per share

Profitability

Net Income$15.30 billion

Miscellaneous

Employees135,100
Outstanding Shares2,639,166,000
Market Cap$342.22 billion
Next Earnings Date10/15/2019 (Confirmed)
OptionableOptionable

Receive JNJ News and Ratings via Email

Sign-up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.


Johnson & Johnson (NYSE:JNJ) Frequently Asked Questions

What is Johnson & Johnson's stock symbol?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?

Johnson & Johnson declared a quarterly dividend on Monday, July 15th. Stockholders of record on Tuesday, August 27th will be paid a dividend of $0.95 per share on Tuesday, September 10th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 2.93%. The ex-dividend date is Monday, August 26th. View Johnson & Johnson's Dividend History.

How will Johnson & Johnson's stock buyback program work?

Johnson & Johnson declared that its board has initiated a stock repurchase plan on Monday, December 17th 2018, which authorizes the company to buyback $5,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 1.5% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board of directors believes its stock is undervalued.

How were Johnson & Johnson's earnings last quarter?

Johnson & Johnson (NYSE:JNJ) posted its quarterly earnings results on Tuesday, July, 16th. The company reported $2.58 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $2.42 by $0.16. The business earned $20.56 billion during the quarter, compared to analysts' expectations of $20.39 billion. Johnson & Johnson had a return on equity of 38.63% and a net margin of 20.08%. Johnson & Johnson's revenue for the quarter was down 1.3% on a year-over-year basis. During the same quarter last year, the business earned $2.10 EPS. View Johnson & Johnson's Earnings History.

When is Johnson & Johnson's next earnings date?

Johnson & Johnson is scheduled to release their next quarterly earnings announcement on Tuesday, October 15th 2019. View Earnings Estimates for Johnson & Johnson.

How can I listen to Johnson & Johnson's earnings call?

Johnson & Johnson will be holding an earnings conference call on Tuesday, October 15th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Johnson & Johnson issued on next quarter's earnings?

Johnson & Johnson issued an update on its FY19 earnings guidance on Tuesday, July, 16th. The company provided earnings per share (EPS) guidance of $8.53-8.63 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.62. The company issued revenue guidance of $80.8-81.6 billion, compared to the consensus revenue estimate of $81.27 billion.

What price target have analysts set for JNJ?

11 analysts have issued twelve-month price targets for Johnson & Johnson's stock. Their forecasts range from $140.00 to $169.00. On average, they expect Johnson & Johnson's share price to reach $151.8889 in the next twelve months. This suggests a possible upside of 17.1% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.

What is the consensus analysts' recommendation for Johnson & Johnson?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Johnson & Johnson.

Has Johnson & Johnson been receiving favorable news coverage?

Headlines about JNJ stock have been trending negative on Tuesday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Johnson & Johnson earned a news impact score of -2.9 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Johnson & Johnson.

Are investors shorting Johnson & Johnson?

Johnson & Johnson saw a increase in short interest during the month of August. As of August 15th, there was short interest totalling 15,811,200 shares, an increase of 7.4% from the July 15th total of 14,719,000 shares. Based on an average daily volume of 7,390,000 shares, the short-interest ratio is presently 2.1 days. Approximately 0.6% of the shares of the company are short sold. View Johnson & Johnson's Current Options Chain.

Who are some of Johnson & Johnson's key competitors?

What other stocks do shareholders of Johnson & Johnson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Verizon Communications (VZ), Cisco Systems (CSCO), Pfizer (PFE), Procter & Gamble (PG), Intel (INTC), Walt Disney (DIS), Exxon Mobil (XOM), JPMorgan Chase & Co. (JPM) and General Electric (GE).

Who are Johnson & Johnson's key executives?

Johnson & Johnson's management team includes the folowing people:
  • Mr. Alex Gorsky, Chairman & CEO (Age 59)
  • Mr. Joseph J. Wolk CPA, Exec. VP & CFO (Age 52)
  • Dr. Paulus A. Stoffels, Chief Scientific Officer (Age 57)
  • Mr. Michael H. Ullmann, Exec. VP & Gen. Counsel (Age 60)
  • Mr. Joaquin Duato, Vice Chairman of Exec. Committee (Age 56)

Who are Johnson & Johnson's major shareholders?

Johnson & Johnson's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.53%), BlackRock Inc. (7.12%), Phocas Financial Corp. (4.74%), Phocas Financial Corp. (4.74%), Northern Trust Corp (1.34%) and Bank of New York Mellon Corp (1.20%). Company insiders that own Johnson & Johnson stock include Alex Gorsky, Charles Prince, Joaquin Duato, Marillyn A Hewson, Michael E Sneed, Paulus Stoffels, Peter Fasolo and Ronald A Kapusta. View Institutional Ownership Trends for Johnson & Johnson.

Which major investors are selling Johnson & Johnson stock?

JNJ stock was sold by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Barrow Hanley Mewhinney & Strauss LLC, Boston Partners, UBS Asset Management Americas Inc., BlackRock Inc., Independent Franchise Partners LLP, Swedbank and Quest Capital Management Inc. ADV. Company insiders that have sold Johnson & Johnson company stock in the last year include Alex Gorsky, Joaquin Duato, Michael E Sneed, Peter Fasolo and Ronald A Kapusta. View Insider Buying and Selling for Johnson & Johnson.

Which major investors are buying Johnson & Johnson stock?

JNJ stock was acquired by a variety of institutional investors in the last quarter, including Phocas Financial Corp., Phocas Financial Corp., Nuveen Asset Management LLC, Thoroughbred Financial Services LLC, Renaissance Technologies LLC, Price T Rowe Associates Inc. MD, APG Asset Management N.V. and Vanguard Group Inc.. Company insiders that have bought Johnson & Johnson stock in the last two years include Charles Prince and Marillyn A Hewson. View Insider Buying and Selling for Johnson & Johnson.

How do I buy shares of Johnson & Johnson?

Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Johnson & Johnson's stock price today?

One share of JNJ stock can currently be purchased for approximately $129.67.

How big of a company is Johnson & Johnson?

Johnson & Johnson has a market capitalization of $342.22 billion and generates $81.58 billion in revenue each year. The company earns $15.30 billion in net income (profit) each year or $8.18 on an earnings per share basis. Johnson & Johnson employs 135,100 workers across the globe.View Additional Information About Johnson & Johnson.

What is Johnson & Johnson's official website?

The official website for Johnson & Johnson is http://www.jnj.com/.

How can I contact Johnson & Johnson?

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at 732-524-0400.


MarketBeat Community Rating for Johnson & Johnson (NYSE JNJ)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  793 (Vote Outperform)
Underperform Votes:  885 (Vote Underperform)
Total Votes:  1,678
MarketBeat's community ratings are surveys of what our community members think about Johnson & Johnson and other stocks. Vote "Outperform" if you believe JNJ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JNJ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Featured Article: Relative Strength Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel